Spyre Therapeutics (SPY) CFO Scott Burrows Sells $2.28M in Shares

Scott Burrows, the CFO of Spyre Therapeutics (SPY), has sold shares valued at $2.28 million. This sale adds to his previous divestitures this year, which may raise questions among investors about insider confidence in the company. The specific number of shares sold and the selling price per share were not disclosed in the announcement. Such insider sales can impact market perception and influence stock performance, making this an important development for investors to watch.